BDBM350545 US10208071, Compound 7::US10434112, Compound 7::US10799518, Compound 7::{[(2S)-2-{[(4-bromo-2- fluorophenyl)carbamoyl]amino}-4- methylpentanoyl]amino}acetic acid

SMILES CC(C)C[C@H](NC(=O)Nc1ccc(Br)cc1F)C(=O)NCC(O)=O

InChI Key InChIKey=GWOULRCUFTYSHG-UHFFFAOYSA-N

Data  4 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 350545   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350545({[(2S)-2-{[(4-bromo-2- fluorophenyl)carbamoyl]amin...)
Affinity DataEC50:  3.57E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350545({[(2S)-2-{[(4-bromo-2- fluorophenyl)carbamoyl]amin...)
Affinity DataEC50:  3.57E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350545({[(2S)-2-{[(4-bromo-2- fluorophenyl)carbamoyl]amin...)
Affinity DataEC50:  3.57E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350545({[(2S)-2-{[(4-bromo-2- fluorophenyl)carbamoyl]amin...)
Affinity DataEC50:  3.60nMAssay Description:Agonist activity at human FPR2 expressed in HEK cells assessed as increase in calcium flux incubated for 40 mins by Fluo-4 staining based FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed